212 related articles for article (PubMed ID: 30291766)
1. Mini photopheresis for refractory chronic graft-versus-host disease in children and adolescents.
Verdú-Amorós J; Woessmann W; Maecker-Kolhoff B; Schulz A; Strauss G; Bein G; Hackstein H
Transfusion; 2018 Nov; 58(11):2495-2500. PubMed ID: 30291766
[TBL] [Abstract][Full Text] [Related]
2. Successful use of miniphotopheresis for the treatment of graft-versus-host disease.
Hackstein H; Amoros JJ; Bein G; Woessmann W
Transfusion; 2014 Aug; 54(8):2022-7. PubMed ID: 24666366
[TBL] [Abstract][Full Text] [Related]
3. An automated mini buffy coat preparation method for use in mini extracorporeal photopheresis treatment of graft-vs-host-disease in a low body weight pediatric patient.
Matic T; Bojanic I; Mazic S; Golubic Cepulic B; Bilic E
J Clin Apher; 2019 Aug; 34(4):468-473. PubMed ID: 30829417
[TBL] [Abstract][Full Text] [Related]
4. Mini buffy coat photopheresis for children and critically ill patients with extracorporeal photopheresis contraindications.
Hackstein H; Misterek J; Nockher A; Reiter A; Bein G; Woessmann W
Transfusion; 2009 Nov; 49(11):2366-73. PubMed ID: 19903292
[TBL] [Abstract][Full Text] [Related]
5. Extracorporeal photopheresis: a useful therapy for patients with steroid-refractory acute graft-versus-host disease but not for the prevention of the chronic form.
Rubegni P; Feci L; Poggiali S; Marotta G; D'Ascenzo G; Murdaca F; Fimiani M
Br J Dermatol; 2013 Aug; 169(2):450-7. PubMed ID: 23534380
[TBL] [Abstract][Full Text] [Related]
6. Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease.
Ilhan O; Arat M; Arslan O; Ayyildiz E; Sanli H; Beksac M; Ozcan M; Gürman G; Akan H
Transfus Apher Sci; 2004 Jun; 30(3):185-7. PubMed ID: 15172621
[TBL] [Abstract][Full Text] [Related]
7. The concurrent administration of imatinib with extracorporeal photopheresis leads to complete and durable responses in patients with refractory sclerotic type chronic graft-versus-host disease.
Alsuliman T; Magro L; Coiteux V; Gauthier J; Srour M; Lionet A; Beauvais D; Yakoub-Agha I
Curr Res Transl Med; 2020 Apr; 68(2):71-76. PubMed ID: 31631014
[TBL] [Abstract][Full Text] [Related]
8. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results.
Apisarnthanarax N; Donato M; Körbling M; Couriel D; Gajewski J; Giralt S; Khouri I; Hosing C; Champlin R; Duvic M; Anderlini P
Bone Marrow Transplant; 2003 Mar; 31(6):459-65. PubMed ID: 12665841
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of extracorporeal photopheresis in pediatric patients with graft-versus-host disease after hematopoietic stem cell transplantation.
Winther-Jørgensen S; Nygaard M; Heilmann C; Ifversen M; Sørensen K; Müller K; Masmas T
Pediatr Transplant; 2019 Jun; 23(4):e13416. PubMed ID: 30973668
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD.
Dignan FL; Greenblatt D; Cox M; Cavenagh J; Oakervee H; Apperley JF; Fielding AK; Pagliuca A; Mufti G; Raj K; Marks DI; Amrolia P; Peniket A; Medd P; Potter MN; Shaw BE; Scarisbrick JJ
Bone Marrow Transplant; 2012 Jun; 47(6):824-30. PubMed ID: 21927038
[TBL] [Abstract][Full Text] [Related]
11. Extracorporeal photopheresis in 62 patients with acute and chronic GVHD: results of treatment with the COBE Spectra System.
Hautmann AH; Wolff D; Hahn J; Edinger M; Schirmer N; Ammer J; Holler B; Landfried K; Hautmann MG; Ahrens N; Ugocsai P; Andreesen R; Holler E
Bone Marrow Transplant; 2013 Mar; 48(3):439-45. PubMed ID: 22922407
[TBL] [Abstract][Full Text] [Related]
12. Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo Osseo.
Malagola M; Cancelli V; Skert C; Leali PF; Ferrari E; Tiburzi A; Sala ML; Donnini I; Chiusolo P; Mussetti A; Battista M; Turra A; Cattina F; Rambaldi B; Schieppati F; Polverelli N; Bernardi S; Perucca S; Marini M; Laszlo D; Savignano C; Patriarca F; Corradini P; Piccirillo N; Sica S; Bosi A; Russo D
Transplantation; 2016 Dec; 100(12):e147-e155. PubMed ID: 27861297
[TBL] [Abstract][Full Text] [Related]
13. Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single-center study.
Sakellari I; Gavriilaki E; Batsis I; Mallouri D; Panteliadou AK; Lazaridou A; Vardi A; Constantinou V; Yannaki E; Papalexandri A; Kaloyannidis P; Smias C; Anagnostopoulos A
J Clin Apher; 2018 Dec; 33(6):654-660. PubMed ID: 30394564
[TBL] [Abstract][Full Text] [Related]
14. Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis--results of a crossover randomized study.
Greinix HT; van Besien K; Elmaagacli AH; Hillen U; Grigg A; Knobler R; Parenti D; Reddy V; Theunissen K; Michallet M; Flowers ME;
Biol Blood Marrow Transplant; 2011 Dec; 17(12):1775-82. PubMed ID: 21621629
[TBL] [Abstract][Full Text] [Related]
15. Extracorporeal Photopheresis: An Efficacious and Well-Tolerated Treatment for Cutaneous and Oral Mucosal Chronic Graft-versus-Host Disease.
Richet C; Huynh A; Dimeglio C; Borel C; Lepage B; Boulinguez S; Marguery MC; Paul C; Bulai Livideanu C
Dermatology; 2018; 234(1-2):23-30. PubMed ID: 29788024
[TBL] [Abstract][Full Text] [Related]
16. [Extracorporeal photopheresis in treatment of chronic graft versus host disease].
Bojanić I; Seiwerth RS; Mazić S; Dubravcić K; Batinić D; Cepulić BG; Labar B
Lijec Vjesn; 2013; 135(5-6):139-44. PubMed ID: 23898694
[TBL] [Abstract][Full Text] [Related]
17. Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.
Weitz M; Strahm B; Meerpohl JJ; Bassler D
Cochrane Database Syst Rev; 2014 Feb; (2):CD009898. PubMed ID: 24569961
[TBL] [Abstract][Full Text] [Related]
18. Real-World Experience in Extracorporeal Photopheresis for Adults with Graft-versus-Host Disease.
Asensi Cantó P; Sanz Caballer J; Sopeña Pell-Ilderton C; Solís Ruiz J; Lloret Madrid P; Villalba Montaner M; Facal Malvar A; Chorão P; Guerreiro M; Balaguer Roselló A; Montoro Gómez J; Santiago Balsera M; Solves Alcaína P; Sanz Alonso MÁ; De la Rubia Comos J; Gómez-Seguí I
Transplant Cell Ther; 2023 Dec; 29(12):765.e1-765.e8. PubMed ID: 37703997
[TBL] [Abstract][Full Text] [Related]
19. Safety and Outcomes of Extracorporeal Photopheresis With the Therakos Cellex System for Graft-Versus-Host Disease in Pediatric Patients.
Uygun V; Daloglu H; Karasu G; Hazar V; Yeşilipek A
J Pediatr Hematol Oncol; 2015 Apr; 37(3):209-14. PubMed ID: 25374287
[TBL] [Abstract][Full Text] [Related]
20. Extracorporeal photopheresis for graft-versus-host disease: the role of patient, transplant, and classification criteria and hematologic values on outcome-results from a large single-center study.
Berger M; Albiani R; Sini B; Fagioli F
Transfusion; 2015 Apr; 55(4):736-47. PubMed ID: 25355659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
